Home
Scholarly Works
Prognostic value of baseline evaluation of FDG and...
Conference

Prognostic value of baseline evaluation of FDG and NaF PET/CT in castrate-resistant prostate cancer (CRPC): Early results from a prospective phase 1 trial

Authors

Zukotynski K; Kim C; Gerbaudo V; Hainer J; Van Den Abbeele A; Seltzer S; Sweeney C

Volume

55

Publisher

SOC NUCLEAR MEDICINE INC

Publication Date

May 1, 2014

Name of conference

Annual Meeting of the Society-of-Nuclear-Medicine-and-Molecular-Imaging (SNMMI)

Conference place

MO, St Louis

Conference start date

June 7, 2014

Conference end date

June 11, 2014

Conference proceedings

JOURNAL OF NUCLEAR MEDICINE

ISSN

0161-5505

Labels

Fields of Research (FoR)

Contact the Experts team